We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
-8.14%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.56B
AUM Growth
-$1.36B
Cap. Flow
-$1.11B
Cap. Flow %
-31.07%
Top 10 Hldgs %
29.11%
Holding
1,521
New
512
Increased
155
Reduced
168
Closed
620

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$193M
2
AMZN icon
Amazon
AMZN
+$126M
3
AMD icon
Advanced Micro Devices
AMD
+$77.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$49.2M
5
XYZ
Block Inc
XYZ
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 2.48%
2 Consumer Discretionary 1.2%
3 Communication Services 1.16%
4 Technology 1.08%
5 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREE icon
726
PUT
LendingTree
TREE
$551M
$251K 0.01%
+2,100
New +$248K
HZON
727
CALL
DELISTED
Horizon Acquisition Corporation II
HZON
$248K 0.01%
25,000
CCL icon
728
Carnival Corporation Ltd
CCL
$38.1B
$246K 0.01%
12,166
-22,834
-65% -$462K
ATHM icon
729
PUT
Autohome
ATHM
$2.62B
$243K 0.01%
+8,000
New +$242K
APRN
730
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$243K 0.01%
+5,000
New +$363K
QNCX icon
731
CALL
Quince Therapeutics
QNCX
$21.5M
$242K 0.01%
+196
New +$267K
KYNB
732
CALL
Kyntra Bio
KYNB
$27.4M
$240K 0.01%
800
-200
-20% -$69.7K
ALTO icon
733
CALL
Alto Ingredients
ALTO
$338M
$239K 0.01%
+35,000
New +$196K
QVCGA
734
DELISTED
QVC Group Inc Series A
QVCGA
$238K 0.01%
+1,000
New +$319K
TBPH icon
735
Theravance Biopharma
TBPH
$873M
$237K 0.01%
+24,800
New +$243K
IMUX icon
736
Immunic
IMUX
$178M
$236K 0.01%
+2,090
New +$242K
PMVP icon
737
CALL
PMV Pharmaceuticals
PMVP
$57.1M
$233K 0.01%
+11,200
New +$198K
FTAI icon
738
FTAI Aviation
FTAI
$20.2B
$232K 0.01%
+10,539
New +$234K
PYPL icon
739
PayPal
PYPL
$49.9B
$231K 0.01%
2,000
-62,500
-97% -$8.32M
COUR icon
740
Coursera
COUR
$1.77B
$230K 0.01%
10,000
-8,500
-46% -$174K
RUBY
741
CALL
DELISTED
Rubius Therapeutics, Inc
RUBY
$227K 0.01%
+41,200
New +$262K
IMUX icon
742
PUT
Immunic
IMUX
$178M
$226K 0.01%
+2,000
New +$232K
HD icon
743
Home Depot
HD
$337B
$224K 0.01%
+750
New +$260K
ELAN icon
744
Elanco Animal Health
ELAN
$13.2B
$222K 0.01%
8,500
-1,500
-15% -$39.9K
PACB icon
745
CALL
Pacific Biosciences
PACB
$435M
$218K 0.01%
24,000
-16,000
-40% -$184K
VTRS icon
746
Viatris
VTRS
$20.8B
$218K 0.01%
20,000
-3,400
-15% -$44.8K
RAD
747
DELISTED
Rite Aid Corporation
RAD
$217K 0.01%
+24,800
New +$260K
AMPH icon
748
CALL
Amphastar Pharmaceuticals
AMPH
$907M
$215K 0.01%
+6,000
New +$170K
ZNTE
749
CALL
DELISTED
Zanite Acquisition Corp. Class A Common Stock
ZNTE
$215K 0.01%
21,000
RNW icon
750
ReNew
RNW
$2.18B
$214K 0.01%
+26,000
New +$188K

Similar funds

SG3 Management's Q1 2022 Portfolio in Review

As of Q1 2022, SG3 Management held 1,521 positions worth $3.56B, down 28% from $4.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

SG3 Management withdrew a net $1.11B in Q1 2022, closing 620 positions and reducing 168 holdings. Its most notable exit was Tesla, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, SG3 Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $13.5M.

  • SG3 Management's largest Q1 2022 buy was State Street SPDR S&P 500 ETF Trust: 30,000 shares worth $13.5M.
  • SG3 Management added most to Bausch Health in Q1 2022, an estimated $27.4M increase.
  • SG3 Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $126M.
  • SG3 Management fully exited Tesla in Q1 2022, selling an estimated $193M.
  • SG3 Management's ten largest holdings make up 29% of its $3.56B portfolio in Q1 2022.
  • SG3 Management opened 512 new positions and closed 620 in Q1 2022.
  • SG3 Management's portfolio value fell 28% quarter-over-quarter to $3.56B.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.